Role of Modified Citrus Pectin in Cancer Treatment Presented at International Oncology Conference
I
recently discussed the principles of integrative medicine in oncology and
shared the latest research on the role of Modified Citrus Pectin (MCP) in the
treatment of cancer at an international oncology conference in Rhodes, Greece.
This conference, titled “The 16th World Congress on Advances in Oncology and
14th International Symposium on Molecular Medicine,” brought together hundreds
of cancer researchers, oncologists and medical professionals from around the
world to share the latest information and advancements in the treatment and
prevention of cancer. The international event was organized by the International
Journal of Oncology, Oncology Reports, International Journal of Molecular
Medicine, and Molecular Medicine Reports, and held in Rodos Palace
Resort on the island of Rhodes, Greece. The scientific program included
presentations by scientists and medical doctors on topics in genetics,
immunology, experimental oncology and brain tumors, among others.
For this presentation, I drew upon my 25+ years of experience as an integrative
physician and researcher to discuss the energetic and philosophical principles
of integrative medicine in oncology and how to apply these principles to cancer
prevention and treatment. This included the latest body of research on Modified
Citrus Pectin and novel polybotanical formulas in suppressing the growth and
proliferation of cancer.
What is Integrative Medicine?
Integrative medicine is a patient-driven, unbiased and individualized form of
medicine that combines both conventional and holistic approaches to treat
people as a whole, rather than focusing solely on diseases and symptoms. It
emphasizes a partnership between the patient and the practitioner in the
healing process, to create individualized programs and promote the body's
inherent healing response. In my presentation, I discussed how integrative medicine
takes into account the whole person - mind, body and spirit - to integrate both
conventional and alternative therapies into uniquely tailored health protocols.
True integrative medicine includes treatments and approaches that are
synergistically combined for clinical outcome that is greater than the sum of
its parts. This can include a combination of conventional drugs, exercise, supplements
and nutrition - but it is also the merging of analytical conceptual thinking
with a limitless ‘non-conceptual’ open-mindedness where anything is possible. Such
a balance paves the way to true healing.
Research on Modified Citrus Pectin and Polybotanicals
I shared recent research on the role of Modified Citrus Pectin
(MCP) and polybotanicals in the treatment of cancer, and explained specifically
how MCP directly attacks cancer by binding to galectin-3 molecules (“sticky”
surface molecules that promote angiogenesis and metastasis) and blocking their
harmful effects, so cancer cells cannot spread and grow.
Over the last decade, a large body of peer-reviewed research has revealed that
many of our most serious health concerns are associated with elevated levels of
galectin-3 molecules. Modified Citrus Pectin - derived from citrus peels - is
the only proven natural galectin-3 inhibitor and thus offers a powerful and
all-natural way to address elevated galectin-3 for cancer, metastasis, and
other chronic life threatening illnesses.
How Does MCP Work?
Food-grade pectin is a complex carbohydrate, a soluble form of fiber, and is
not digested by humans. However, when citrus pectin is modified to reduce the
length of the fiber chains and the amount of bulky cross-linking side groups,
it can be made absorbable. As a result, MCP enters the circulatory system and
reaches targeted areas of the body. MCP is structurally a poly galacturonic
acid fiber, made up of glactose subunits, which has been shown to suppress
cancer growth and metastases in multiple preclinical and clinical studies. In
prostate cancer patients, MCP has been shown to increase the prostate-specific
antigen (PSA) doubling time, and has also been shown to increase the quality of
life in people with advanced stage cancers of multiple types of solid tumors.
The anticancer effects are attributed to MCP being a natural ligand for
galectin-3 molecules, inhibiting the over-expressed galectin-3 molecules that
are present on the surface of cancer cells and circulating in the blood.
Galectin-3 has been implicated in multiple pathological processes including
abnormal proliferation, angiogenesis, apoptosis, inflammation and fibrosis.
I also presented recent research on the successful treatment of highly
invasive, hormone-dependent and independent prostate and breast
cancer cells using MCP, a novel
poly-botanical formula for prostate cancer and another formula for breast
cancer. These combinations significantly further enhanced inhibition of the
invasive behavior of breast and prostate cancer cells, respectively. I concluded my presentation with an explanation of the role
of the botanical extract Honokiol, and its synergistic effects in combination
with polybotanicals, chemotherapy agents and MCP for the treatment of cancer.
For more information about Modified Citrus Pectin, download a wellness guide at
www.mcpreport.com.
|
